Explore CRISPR technology explained, gene editing science, DNA modification, and genetic engineering ethics—discover how ...
In a world first, a bespoke gene-editing therapy benefited one child. Now researchers plan to launch a clinical trial of the ...
A company’s plan to edit the genomes of human embryos worries some researchers — but it might reflect the changing attitudes towards the controversial approach.
Interesting Engineering on MSN
New plant system triggers crops to grow themselves with genetic upgrades
Graduate student Arjun Ojha Kshetry and colleagues combined two key genes: WIND1, which reprograms cells near a wound, and ...
A poorly characterized protein, historically thought to be a chaperon or enzyme, may actually be a key player in prostate ...
We have written about the promise of gene therapy to correct genetic disease many times. An exciting development happened ...
Emerging biotechnologies, strategic collaborations, and growing focus on personalized and regenerative medicine are accelerating the next wave of gene therapy innovation.Austin, Nov. 05, 2025 (GLOBE ...
Two days after Intellia voluntarily paused dosing due to safety concerns, the regulator stepped in with an official hold that ...
Vinay Prasad, chief of the FDA’s Center for Biologics Evaluation and Research, is planning to publish a paper this month to ...
Recognized in the Biotechnology category of the 2025 Top Innovations contest, small Cas12l nucleases are versatile, ...
Jarome and his team found that aging disrupts K63 polyubiquitination in two distinct areas of the brain. In the hippocampus, ...
13d
Crispr And Intellia: Advancing In Vivo Gene Editing As 2025 Results Strengthen Investment Outlook
Both CRSP and NTLA are advancing in vivo gene editing therapies targeting large markets, with financial stability supporting ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback